INDICAID® COVID-19 Rapid Antigen Test (FDA EUA, CE) is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.
Fast: Intuitive visual results in 20 minutes
Accurate: Clinically validated with overall sensitivity and specificity at 96% and 99% respectively
Easy-to-Use: No special equipment or facilities are needed
Product Certification: The first COVID-19 product in Greater China that authorized by US FDA EUA for emergency use, EU CE mark